SHREE GANESH REMEDIES
Back to Balance Sheet
|
SHREE GANESH REMEDIES Last 5 Year Total Non-Current Liabilities History
[Consolidated]
| Mar2025 | Mar2024 | Mar2020 | Mar2019 | |
|---|---|---|---|---|
| Total Non-Current Liabilities | ₹31 Cr | ₹30 Cr | ₹2.65 Cr | ₹0.73 Cr |
What is the latest Total Non-Current Liabilities ratio of SHREE GANESH REMEDIES ?
| Year | Total Non-Current Liabilities |
|---|---|
| Mar2025 | ₹31 Cr |
| Mar2024 | ₹30 Cr |
| Mar2020 | ₹2.65 Cr |
| Mar2019 | ₹0.73 Cr |
How is Total Non-Current Liabilities of SHREE GANESH REMEDIES Trending?
| Years | Total Non-Current Liabilities | % Change | |
|---|---|---|---|
| Mar2025 | ₹31 Cr | 1.48 | |
| Mar2024 | ₹30 Cr | 1,037.96 | |
| Mar2020 | ₹2.65 Cr | 264.01 | |
| Mar2019 | ₹0.73 Cr | - | |
Compare Total Non-Current Liabilities of peers of SHREE GANESH REMEDIES
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| SHREE GANESH REMEDIES | ₹605.3 Cr | 2.4% | -1.4% | -36.1% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹396,370.0 Cr | -2.3% | -8.5% | -3% | Stock Analytics | |
| DIVIS LABORATORIES | ₹161,193.0 Cr | 5.3% | -3.4% | 3.4% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹141,438.0 Cr | 3.7% | -4.9% | 26% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹103,097.0 Cr | 1.2% | -4.2% | 5.3% | Stock Analytics | |
| CIPLA | ₹97,846.7 Cr | 2.4% | -7.2% | -18.1% | Stock Analytics | |
SHREE GANESH REMEDIES Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| SHREE GANESH REMEDIES | 2.4% |
-1.4% |
-36.1% |
| SENSEX | 3.7% |
-0.9% |
0.7% |
You may also like the below Video Courses